PharmaCyte Biotech Inc (PMCB)

[DragonBear]

Going to put a damper on the narrow myopic pathways route for cancers, because those pathways as seen with EI Lily do not always work

Then one better put a "damper" on everything associated with cancer treatments.

Does doxorubicin a chemo anthracycline work for PC? No. Is it extremely useful for breast and lymphoma cancers? Absolutely

Does Eli Lilly's pegilodecakin which is more an immunotherapy drug, than a targeted pathway drug, works with PC? No. Will it work for renal, and lung cancers? Yet to be determined.

We have apparently the mistaken idea that since Lilly's drug is ineffective in stimulating an immune response against the PC tumor, that means the various ongoing CTs with targeted pathway drugs are "myopic". Never mind the Lilly example is an immunotherapy drug. They're all the same aren't they?

Whereas it's concluded Chemo of the past is the future for PC. Why? Not because the majority of chemo drugs are ineffective against PC. Rather it's because the Kenny Wonder Treatment involves Chemotherapy. Yippee!

What is curious is despite the Kenny Wonder Treatment having no patent protection, no one is in competition with PMCB to get it to market. Instead despite the claimed "narrow myopic pathways route", that's exactly what is being investigated in CTs. And what's this...

Hidalgo must be miopic!

That's right, Hidalgo the apparently "myopic" one has been a lead investigator for CXCR4 antagonist BL-8040 in combination with the PD-1 inhibitor pembrolizumab. Maybe that makes him double myopic? A traitor to the Kenny Wonder Treatment-Grrrr! Also someone should Email Hidalgo, and tell him he has wasted the last 10 yrs of his life giving presentations on potential pathway targeted therapies. And to get with the Kenny Wonder Treatment program, show a little loyalty. If he wants his next PMCB consulting check, he better start giving presentations on the Kenny Wonder Treatment as the future - something he has never done. Poor(?)Kenny can't pull the load by himself.